AIM ImmunoTech (AIM) Change in Cash (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Change in Cash came in at $2.8 million in Q1 2026, up 452.55% YoY from $512349.1 in Q1 2025, and up 343.73% on a QoQ basis from $638000.0 in Q4 2025.
AIM ImmunoTech (AIM) Change in Cash (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Change in Cash data on file, last reported at $2.8 million in Q1 2026.
- Quarterly Change in Cash rose 452.55% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 305.17% YoY) and the FY2025 annual result came in at $1.3 million, up 134.35% from the prior year.
- Change in Cash rose to $2.8 million in Q1 2026, from $638000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $5.5 million in Q2 2022 to a low of -$9.8 million in Q4 2023.
- A 5-year average of -$1.5 million and a median of -$2.1 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 263.08% — and 2026, when it jumped 452.55%.
- Tracing AIM's Change in Cash over 5 years: stood at -$2.7 million in 2022, then plunged by 263.08% to -$9.8 million in 2023, then jumped by 108.0% to $786000.0 in 2024, then slipped by 18.83% to $638000.0 in 2025, then surged by 343.73% to $2.8 million in 2026.
- The last three Change in Cash figures came in at $2.8 million (Q1 2026), $638000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Mn |
| Mar 31, 2026 | 2.83 Mn |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | -422,000.00 |
| Mar 31, 2025 | -803,000.00 |
| Dec 31, 2024 | 786,000.00 |
| Sep 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | 259,000.00 |
| Mar 31, 2024 | -2.14 Mn |
| Dec 31, 2023 | -9.83 Mn |
| Sep 30, 2023 | -5.77 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Mar 31, 2023 | -3.66 Mn |
| Dec 31, 2022 | -2.71 Mn |
| Sep 30, 2022 | -4.69 Mn |
| Jun 30, 2022 | 5.46 Mn |
| Mar 31, 2022 | -3.10 Mn |
| Dec 31, 2021 | -5.26 Mn |
| Sep 30, 2021 | -3.79 Mn |